Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma, HCPs, and organizations looking to thrive in the digital age...
Read MoreTop Stories
Cactus Life Sciences Announces the Acquisition
FOR IMMEDIATE RELEASE Princeton, NJ, April 24, 2024 - Cactus...
Cactus Life Sciences Appoints Oliver Dennis to
Princeton, NJ, April 16, 2024 - Cactus Life Sciences, a...
Optimizing Medical Affairs with Modular Content:
Turn your organization into an “efficiency powerhouse” with...
Filter
How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead
The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
Preprints, MedRxiv, and Pharma – An Overview
Non-peer reviewed and unpublished manuscripts, aka preprints, are slowly being embraced by the pharma industry...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
Knowledge Exchange in a New Virtual World: How the Pandemic Redefined MSL-HCP Interactions
The pandemic threw a curve ball at MSL-HCP relationships, which have traditionally relied on face-to-face...
US FDA (Food And Drug Administration) Social Medial Usage Guidelines: Compliance for Pharma Companies
This poster presents results of an analysis of trends in adherence of pharmaceutical companies to...
The Battle for Evidence-Based Truth in a War of Misinformation
I was talking to someone I know — let’s call her Joanna — about the...